Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective

被引:117
作者
de Joode, K. [1 ,2 ]
Dumoulin, D. W. [3 ]
Engelen, V. [4 ]
Bloemendal, H. J. [5 ]
Verheij, M. [6 ,7 ]
van Laarhoven, H. W. M. [8 ]
Dingemans, I. H. [4 ]
Dingemans, A. C. [3 ,9 ]
van der Veldt, A. A. M. [1 ,2 ]
机构
[1] Erasmus MC, Canc Inst, Dept Med Oncol, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[3] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands
[4] Dutch Federat Canc Patient Org, Utrecht, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Nijmegen, Netherlands
[6] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[8] Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[9] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, Dept Pulm Dis GROW, Maastricht, Netherlands
关键词
Coronavirus; COVID-19; Pandemic; Cancer; Patients' perspective; LUNG-CANCER;
D O I
10.1016/j.ejca.2020.06.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has inevitable consequences for medical care of patients without COVID-19. To assess the impact of this pandemic on oncological care, a nationwide survey was conducted among patients with cancer in the Netherlands. Methods: The patients' perspective on oncological care was investigated using an online survey between March 29th 2020 and April 18th 2020. The survey consisted of 20 questions on four topics: patients' characteristics, contact with the hospital, consequences of the COVID-19 pandemic and concerns about COVID-19. Results: Five thousand three hundred two patients with cancer completed this nationwide survey. Overall, 30% of patients reported consequences for their oncological treatment or follow-up. In the majority of cases, this resulted in conversion from hospital visit to consultation by phone or video. The most frequently adjusted treatments were chemotherapy (30%) and immunotherapy (32%). Among patients with delay and discontinuation of treatment, 55% and 63% of patients, respectively, were (very) concerned about these consequences of the COVID-19 pandemic. Consequences were independent of regional differences in COVID-19 incidence. However, patients in regions with high COVID-19 incidence were significantly more concerned. Conclusion: This is the first study investigating perspectives of patients with cancer during the COVID-19 pandemic. The study demonstrates the significant impact of the COVID-19 crisis on oncological care, indicating the need for psycho-oncological support during this pandemic. (C) 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:132 / 139
页数:8
相关论文
共 26 条
[1]  
[Anonymous], COVID 19
[2]  
[Anonymous], GEV COR KANK WAT JOU
[3]   How we treat patients with lung cancer during the SARS-CoV-2 pandemic:primum non nocere [J].
Banna, Giuseppe ;
Curioni-Fontecedro, Alessandra ;
Friedlaender, Alex ;
Addeo, Alfredo .
ESMO OPEN, 2019, 4
[4]  
Bruins B, 2020, COVID 19 NIEUWE AANV
[5]  
Cancer Research UK, 2020, CANC SCREEN COR COVI
[6]   Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Publication with Expression of Concern) [J].
Corman, Victor M. ;
Landt, Olfert ;
Kaiser, Marco ;
Molenkamp, Richard ;
Meijer, Adam ;
Chu, Daniel K. W. ;
Bleicker, Tobias ;
Bruenink, Sebastian ;
Schneider, Julia ;
Schmidt, Marie Luisa ;
Mulders, Daphne G. J. C. ;
Haagmans, Bart L. ;
van der Veer, Bas ;
van den Brink, Sharon ;
Wijsman, Lisa ;
Goderski, Gabriel ;
Romette, Jean-Louis ;
Ellis, Joanna ;
Zambon, Maria ;
Peiris, Malik ;
Goossens, Herman ;
Reusken, Chantal ;
Koopmans, Marion P. G. ;
Drosten, Christian .
EUROSURVEILLANCE, 2020, 25 (03) :23-30
[7]   Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak [J].
Dai, Mengyuan ;
Liu, Dianbo ;
Liu, Miao ;
Zhou, Fuxiang ;
Li, Guiling ;
Chen, Zhen ;
Zhang, Zhian ;
You, Hua ;
Wu, Meng ;
Zheng, Qichao ;
Xiong, Yong ;
Xiong, Huihua ;
Wang, Chun ;
Chen, Changchun ;
Xiong, Fei ;
Zhang, Yan ;
Peng, Yaqin ;
Ge, Siping ;
Zhen, Bo ;
Yu, Tingting ;
Wang, Ling ;
Wang, Hua ;
Liu, Yu ;
Chen, Yeshan ;
Mei, Junhua ;
Gao, Xiaojia ;
Li, Zhuyan ;
Gan, Lijuan ;
He, Can ;
Li, Zhen ;
Shi, Yuying ;
Qi, Yuwen ;
Yang, Jing ;
Tenen, Daniel G. ;
Chai, Li ;
Mucci, Lorelei A. ;
Santillana, Mauricio ;
Cai, Hongbing .
CANCER DISCOVERY, 2020, 10 (06) :783-791
[8]  
De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166
[9]   Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic [J].
Dingemans, Anne-Marie C. ;
Soo, Ross A. ;
Jazieh, Abdul Rahman ;
Rice, Shawn J. ;
Kim, Young Tae ;
Teo, Lynette L. S. ;
Warren, Graham W. ;
Xiao, Shu-Yuan ;
Smit, Egbert F. ;
Aerts, Joachim G. ;
Yoon, Soon Ho ;
Veronesi, Giulia ;
De Cobelli, Francesco ;
Ramalingam, Suresh S. ;
Garassino, Marina C. ;
Wynes, Murry W. ;
Behera, Madhusmita ;
Haanen, John ;
Lu, Shun ;
Peters, Solange ;
Ahn, Myung-Ju ;
Scagliotti, Giorgio V. ;
Adjei, Alex A. ;
Belani, Chandra P. .
JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) :1119-1136
[10]   Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment [J].
Dinmohamed, Avinash G. ;
Visser, Otto ;
Verhoeven, Rob H. A. ;
Louwman, Marieke W. J. ;
van Nederveen, Francien H. ;
Willems, Stefan M. ;
Merkx, Matthias A. W. ;
Lemmens, Valery E. P. P. ;
Nagtegaal, Iris D. ;
Siesling, Sabine .
LANCET ONCOLOGY, 2020, 21 (06) :750-751